Thu-12-05-2016, 20:59 PM
That's a tough one. The problem I see with biologics is the cost and until that is driven down, insurance companies will continue to push some of the older (and cheaper) options.
There does seem to be a lot of new biologics being available so for the near future I think that is where things are heading. As for years from now... hard to say.
There does seem to be a lot of new biologics being available so for the near future I think that is where things are heading. As for years from now... hard to say.